Monotherapy conventional synthetic DMARD (csDMARDs; methotrexate preferred) is the drug of choice for treatment-naive patients with early or established rheumatoid arthritis for any level of disease activity according to the American College of Rheumatology 2015 Guidelines. When monotherapy with a csDMARD has been ineffective or partially effect...